Add to ORKGChapter 1 offers an introduction in which the place of vasodilator therapy in heart failure is described. A review of the relevant studies with vasodilating drugs is presented. In the second part, the methodological problems in heart failure research are analyzed. In the third part the results of published studies with felodipine in congestive heart failure are discussed ,together with the results of studies in other circulatory diseases.
The evaluation of the long-term treatment of heart failure is complicated by many biological, clinic...
This chapter addresses the state of knowledge in the evidence-based management of heart failure (HF)...
Oral vasodilators have proved to be valuable drugs in the management of systolic or diastolic conges...
In a randomized, parallel, double‐blind study felodipine was administered to 11 and placebo to 12 pa...
The current status of the use of vasodilator drugs in the treatment of acute and chronic heart failu...
In 13 patients with congestive heart failure we tested the acute hemodynamic effects of 5 vs. 10 mg ...
In congestive heart failure patients the kinetics of felodipine, a dihydropyridine calcium antagonis...
Peak and trough concentrations after 8 weeks oral therapy with felodipine, a vasodilating calciumant...
pacing. The systemic and coronary haemodynamic effects of felodipine were evaluated at rest and duri...
The value of vasodilator therapy in acute and chronic heart failure is well established. Vasodilator...
Vasodilators currently prescribed in the treatment of congestive heart failure represent a wide clas...
AbstractCongestive heart failure is a common clinieal syndrome, with a relatively poor prognosis in ...
Although substantial progress has been made in the last 5 years in the development of vasodilator an...
Cardiovascular diseases are the leading cause of death both in the world and in the Russian Federati...
The purpose of this paper is to review various factors of the control of cardiac contractility and o...
The evaluation of the long-term treatment of heart failure is complicated by many biological, clinic...
This chapter addresses the state of knowledge in the evidence-based management of heart failure (HF)...
Oral vasodilators have proved to be valuable drugs in the management of systolic or diastolic conges...
In a randomized, parallel, double‐blind study felodipine was administered to 11 and placebo to 12 pa...
The current status of the use of vasodilator drugs in the treatment of acute and chronic heart failu...
In 13 patients with congestive heart failure we tested the acute hemodynamic effects of 5 vs. 10 mg ...
In congestive heart failure patients the kinetics of felodipine, a dihydropyridine calcium antagonis...
Peak and trough concentrations after 8 weeks oral therapy with felodipine, a vasodilating calciumant...
pacing. The systemic and coronary haemodynamic effects of felodipine were evaluated at rest and duri...
The value of vasodilator therapy in acute and chronic heart failure is well established. Vasodilator...
Vasodilators currently prescribed in the treatment of congestive heart failure represent a wide clas...
AbstractCongestive heart failure is a common clinieal syndrome, with a relatively poor prognosis in ...
Although substantial progress has been made in the last 5 years in the development of vasodilator an...
Cardiovascular diseases are the leading cause of death both in the world and in the Russian Federati...
The purpose of this paper is to review various factors of the control of cardiac contractility and o...
The evaluation of the long-term treatment of heart failure is complicated by many biological, clinic...
This chapter addresses the state of knowledge in the evidence-based management of heart failure (HF)...
Oral vasodilators have proved to be valuable drugs in the management of systolic or diastolic conges...